Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Debt to Equity (2022 - 2025)

Envoy Medical's Debt to Equity history spans 4 years, with the latest figure at -$0.31 for Q2 2025.

  • For Q2 2025, Debt to Equity fell 54.5% year-over-year to -$0.31; the TTM value through Jun 2025 reached -$0.31, down 54.5%, while the annual FY2024 figure was -$0.99, 467.24% down from the prior year.
  • Debt to Equity for Q2 2025 was -$0.31 at Envoy Medical, up from -$0.95 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.05 in Q3 2023 and bottomed at -$0.99 in Q4 2024.
  • The 4-year median for Debt to Equity is -$0.26 (2024), against an average of -$0.42.
  • The largest annual shift saw Debt to Equity tumbled 1792.0% in 2023 before it plummeted 54.5% in 2025.
  • A 4-year view of Debt to Equity shows it stood at -$0.01 in 2022, then crashed by 1792.0% to -$0.18 in 2023, then crashed by 467.24% to -$0.99 in 2024, then surged by 68.64% to -$0.31 in 2025.
  • Per Business Quant, the three most recent readings for COCH's Debt to Equity are -$0.31 (Q2 2025), -$0.95 (Q1 2025), and -$0.99 (Q4 2024).